1. Immune checkpoint inhibition and its relationship with hypermutation phenoytype as a potential treatment for Glioblastoma

   • Manohan Sinnadurai
   • Kerrie L. McDonald

   Topic Review 14 March 2017 Pages: 359 - 372

   

2. N-(p-coumaroyl) serotonin inhibits glioblastoma cells growth through triggering S-phase arrest and apoptosis

   • Diamanto Lazari
   • George A. Alexiou
   • Athanasios P. Kyritsis

   Laboratory Investigation 01 April 2017 Pages: 373 - 381

   

3. Serum amyloid A1 is upregulated in human glioblastoma

   • Franciele Hinterholz Knebel
   • Miyuki Uno
   • Ana Campa

   Laboratory Investigation 11 March 2017 Pages: 383 - 391

   

4. Rutin increases the cytotoxicity of temozolomide in glioblastoma via autophagy inhibition

   • Pingde Zhang
   • Stella Sun
   • Gilberto Ka Kit Leung

   Laboratory Investigation 14 March 2017 Pages: 393 - 400

   

5. Plasma and cerebrospinal fluid pharmacokinetics of select chemotherapeutic agents following intranasal delivery in a non-human primate model

   • James C. League-Pascual
   • Cynthia M. Lester-McCully
   • Katherine E. Warren

   Laboratory Investigation 13 March 2017 Pages: 401 - 407

   

6. Overexpression of NIMA-related kinase 2 is associated with poor prognoses in malignant glioma

   • Huajie Liu
   • Bin Liu
   • Qi Pang

   Laboratory Investigation 21 March 2017 Pages: 409 - 417

   

7. Benefit of re-operation and salvage therapies for recurrent glioblastoma multiforme: results from a single institution

   • M. Azoulay
   • F. Santos
   • Bassam S. Abdulkarim

   Clinical Study 03 April 2017 Pages: 419 - 426

   

8. Choroid plexus tumors in adult and pediatric populations: the Cleveland Clinic and University Hospitals experience

   • Michal Bahar
   • Hasan Hashem
   • Johannes Wolff

   Clinical Study 13 March 2017 Pages: 427 - 432

   

9. Relationship between magnetic resonance imaging characteristics and plasmatic levels of MMP2 and MMP9 in patients with recurrent high-grade gliomas treated by Bevacizumab and Irinotecan

   • Patrizia Farina
   • Emeline Tabouret
   • Olivier Chinot

   Clinical Study 06 March 2017 Pages: 433 - 437

   

10. Characterization of the peripheral neuropathy associated with brentuximab vedotin treatment of Mycosis Fungoides and Sézary Syndrome

    • Zachary A. Corbin
    • Annie Nguyen-Lin
    • Seema Nagpal

    Clinical Study 07 March 2017 Pages: 439 - 446

    

11. The effect of socioeconomic status on gross total resection, radiation therapy and overall survival in patients with gliomas

    • Sayantan Deb
    • Arjun Vivek Pendharkar
    • Atman Desai

    Clinical Study 03 March 2017 Pages: 447 - 453

    

12. Outcomes of postoperative stereotactic radiosurgery to the resection cavity versus stereotactic radiosurgery alone for melanoma brain metastases

    • Giuseppe Minniti
    • Sergio Paolini
    • Mattia Osti

    Clinical Study 04 March 2017 Pages: 455 - 462

    

13. Neutrophil–lymphocyte ratio dynamics during concurrent chemo-radiotherapy for glioblastoma is an independent predictor for overall survival

    • Matthew Mason
    • Catherine Maurice
    • Caroline Chung

    Clinical Study 22 March 2017 Pages: 463 - 471

    

14. Clival paragangliomas: a report of two cases involving the midline skull base and review of the literature

    • Jacob Ruzevick
    • Eun Kyung Koh
    • Manuel Ferreira

    Clinical Study 16 March 2017 Pages: 473 - 478

    

15. Comparing available criteria for measuring brain metastasis response to immunotherapy

    • Jack M. Qian
    • Amit Mahajan
    • Veronica L. S. Chiang

    Clinical Study 08 March 2017 Pages: 479 - 485

    

16. Chordoid glioma of the third ventricle: report of a rapidly progressive case

    • Amalie A. Erwood
    • Jose E. Velazquez-Vega
    • Daniel J. Brat

    Clinical Study 18 March 2017 Pages: 487 - 495

    

17. Demographics, patterns of care, and survival in pediatric medulloblastoma

    • Emily V. Dressler
    • Therese A. Dolecek
    • John L. Villano

    Clinical Study 13 March 2017 Pages: 497 - 506

    

18. Incidence of CNS tumors in Appalachian children

    • Bin Huang
    • Alice Luo
    • John L. Villano

    Clinical Study 11 March 2017 Pages: 507 - 512

19. The effect of regadenoson on the integrity of the human blood–brain barrier, a pilot study

    • Sadhana Jackson
    • Richard T. George
    • Stuart A. Grossman

    Clinical Study 17 March 2017 Pages: 513 - 519

    

20. Glioblastoma recurrence, progression, and dissemination as a purely subdural gliosarcoma

    • R. Michael Meyer
    • Charles A. Miller
    • Michael S. Dirks

    Letter to the Editor 13 March 2017 Pages: 521 - 522

    

21. Tumor types, breast tumor subtypes and extension of systemic disease may influence outcome in cancer patients with brain metastases

    • Kadri Altundag

    Letter to the Editor 02 March 2017 Pages: 523 - 523

22. Radio-sensitising effect of T-DM1 should not be discarded for the efficacy of radiosurgery in the management of brain metastases in patients with HER2-positive metastatic breast cancer

    • Kadri Altundag

    Letter to the Editor 23 March 2017 Pages: 525 - 525